Every step of the way: integrins in cancer progression and metastasis (vol 18, pg 533, 2018)

被引：25

作者：

Hamidi, Hellyeh

Ivaska, Johanna

机构：

[1] University of Turku and Åbo Akademi University,Turku Centre for Biotechnology

[2] University of Turku,Department of Biochemistry

来源：

NATURE REVIEWS CANCER | 2019年 / 19卷 / 03期

关键词：

D O I：

10.1038/s41568-019-0112-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In the originally published article, pertuzumab was incorrectly described as an anti-PI3K therapy in the section ‘Integrins in anticancer therapy’. The sentence should read ‘In mouse mammary tumour models, increased collagen levels and increased β1 integrin and SRC activity have been demonstrated to accompany, and promote, combined resistance to anti-human epidermal growth factor receptor 2 (HER2; also known as ERBB2) (trastuzumab and pertuzumab) and anti-PI3K (buparlisib) therapies164.’ This has now been corrected in all versions of the original article.

引用

页码：179 / 179

页数：1